Direct activation of mTOR in B lymphocytes confers impairment in B‐cell maturation andloss of marginal zone B cells
Open Access
- 15 June 2011
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 41 (8), 2390-2396
- https://doi.org/10.1002/eji.201041336
Abstract
The tuberous sclerosis complex (TSC), composed of TSC1/TSC2 heterodimers, is inhibitory to the mammalian target of rapamycin (mTOR). Deletion of either TSC1 or TSC2 renders mTOR constitutively active. To directly explore the impact of mTOR activation on B-cell development, we conditionally deleted TSC1 in murine B cells. This led to impairment in B-cell maturation. Unexpectedly, and in contrast to Akt activation, marginal zone (MZ) B cells were significantly reduced. Administration of rapamycin partially corrected the MZ defect, indicating a direct role for mTOR in controlling MZ development. When challenged with a T-cell-dependent antigen, TSC1 KO mice responded less efficiently. Consistent with the MZ defects, TSC1 KO mice did not respond at all to T-independent antigens. Because activation of Akt upstream of TSC and mTOR yields the reverse phenotype with respect to MZ development, we conclude that, physiologically, Akt simultaneously emits two opposing signals that counterbalance each other in the control of B-cell differentiation.Keywords
This publication has 23 references indexed in Scilit:
- Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and StressMolecular Cell, 2010
- The Mammalian Target of Rapamycin: Linking T Cell Differentiation, Function, and MetabolismImmunity, 2010
- mTOR regulates memory CD8 T-cell differentiationNature, 2009
- Common corruption of the mTOR signaling network in human tumorsOncogene, 2008
- The AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cellsThe Journal of Experimental Medicine, 2008
- Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKBMolecular Cell, 2006
- Rapamycin is active against B-precursor leukemiain vitroandin vivo, an effect that is modulated by IL-7-mediated signalingProceedings of the National Academy of Sciences of the United States of America, 2003
- Tor-Mediated Induction of Autophagy via an Apg1 Protein Kinase ComplexThe Journal of cell biology, 2000
- Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1/S-phase growth arrest in T lymphocytes.Published by Elsevier BV ,1993
- Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in YeastScience, 1991